The National Institute for Health and Care Excellence (NICE) and the Ethical Medicines Industry Group (EMIG) have announced a new collaboration to improve companies’ experience as they go through the NICE processes. The collaboration will involve a number of activities, such as seminars and site visits, aimed at EMIG’s unique mix of small, medium and larger companies producing medicines, devices and diagnostics. The new links could be a real boost to EMIG members, whose products make up 50% of the UK’s branded medicine sales by volume.
Jeanette Kusel, director of NICE Scientific Advice, said:
“NICE considers it crucial to have a direct line of communication with stakeholders and this collaboration will give us access to more than 270 life sciences companies, institutions and organisations, so they can learn more about how NICE works and to help them understand how to get the most out of their interactions with us”
Leslie Galloway, Chair of EMIG, said:
“We are delighted to be working with NICE on this programme of engagement. NICE can at times be complex to navigate and opening up a dialogue will serve to dispel myths, prevent common mistakes and smooth the submission process for companies and organisations.”